BABISS, LEE,CLARK, MATTHEW,KEEFE, ANTHONY D.,MULVIHILL, MARK J.,NI, HAIHONG,RENZETTI, LOUIS,RUEBSAM, FRANK,WANG, CE,XIE, ZHIFENG,ZHANG, YING
申请号：
CA2943874
公开号：
CA2943874A1
申请日:
2015.04.03
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.
